SG13489G - Stable plurilamellar vesicles - Google Patents

Stable plurilamellar vesicles

Info

Publication number
SG13489G
SG13489G SG134/89A SG13489A SG13489G SG 13489 G SG13489 G SG 13489G SG 134/89 A SG134/89 A SG 134/89A SG 13489 A SG13489 A SG 13489A SG 13489 G SG13489 G SG 13489G
Authority
SG
Singapore
Prior art keywords
stable plurilamellar
plurilamellar vesicles
vesicles
stable
plurilamellar
Prior art date
Application number
SG134/89A
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/476,496 external-priority patent/US4522803A/en
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of SG13489G publication Critical patent/SG13489G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG134/89A 1982-03-29 1989-02-28 Stable plurilamellar vesicles SG13489G (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36299582A 1982-03-29 1982-03-29
US36299482A 1982-03-29 1982-03-29
US41146682A 1982-08-25 1982-08-25
US44724782A 1982-12-06 1982-12-06
US46390083A 1983-02-04 1983-02-04
US06/476,496 US4522803A (en) 1983-02-04 1983-03-24 Stable plurilamellar vesicles, their preparation and use

Publications (1)

Publication Number Publication Date
SG13489G true SG13489G (en) 1989-07-07

Family

ID=27559847

Family Applications (1)

Application Number Title Priority Date Filing Date
SG134/89A SG13489G (en) 1982-03-29 1989-02-28 Stable plurilamellar vesicles

Country Status (14)

Country Link
EP (1) EP0092453B1 (enExample)
AU (1) AU564876B2 (enExample)
DD (1) DD210217A5 (enExample)
DE (1) DE3373273D1 (enExample)
DK (1) DK163105C (enExample)
FI (1) FI83161C (enExample)
GR (1) GR78163B (enExample)
HK (1) HK96190A (enExample)
IE (1) IE54706B1 (enExample)
IL (1) IL68250A (enExample)
NZ (1) NZ203746A (enExample)
PT (1) PT76476B (enExample)
SG (1) SG13489G (enExample)
WO (1) WO1983003383A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3486459D1 (de) * 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
CH668554A5 (de) * 1984-04-09 1989-01-13 Sandoz Ag Liposomen welche polypeptide mit interleukin-2-aktivitaet enthalten sowie verfahren zu ihrer herstellung.
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
EP0179660A3 (en) * 1984-10-26 1987-08-12 The Liposome Company, Inc. Multilayered vesicles prepared by reverse-phase evaporation
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
EP0231261B1 (en) * 1985-07-05 1994-04-06 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
AU609387B2 (en) * 1986-03-26 1991-05-02 Syntex (U.S.A.) Inc. Liquid single reagent for assays
US5068198A (en) * 1986-03-26 1991-11-26 Syntex (U.S.A.) Inc. Liquid single reagent for assays involving confining gels
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
CA1320130C (en) * 1986-06-12 1993-07-13 Alan L. Weiner Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
PT85537B (pt) * 1986-08-18 1990-06-29 Univ Texas Processo para a preparacao de um sistema de administracao farmaceutica contendo peptidos apresentando quimiotaxia
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
MXPA03004095A (es) 2000-11-09 2004-09-10 Neopharm Inc Complejos de sn-38 con lipidos y sus metodos de uso.
WO2003030864A1 (en) 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
DE102008005673A1 (de) * 2008-01-23 2009-08-20 Universität Augsburg Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen
US10307491B2 (en) 2015-01-30 2019-06-04 The Regents Of The University Of Michigan Liposomal particles comprising biological molecules and uses thereof
JP2018516847A (ja) 2015-03-25 2018-06-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 生体高分子薬を送達するための組成物及び方法
US20210093565A1 (en) * 2016-01-19 2021-04-01 The Regents Of The University Of Michigan Vesicle-encapsulated socs
CA3028721A1 (en) 2016-06-20 2017-12-28 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
US11278493B2 (en) 2018-12-10 2022-03-22 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
CH624011A5 (enExample) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Also Published As

Publication number Publication date
HK96190A (en) 1990-11-30
WO1983003383A1 (en) 1983-10-13
AU1519683A (en) 1983-10-24
DE3373273D1 (de) 1987-10-08
NZ203746A (en) 1987-03-06
DK544883D0 (da) 1983-11-28
FI83161B (fi) 1991-02-28
IL68250A0 (en) 1983-06-15
DK544883A (da) 1983-11-28
DK163105B (da) 1992-01-20
FI834364A7 (fi) 1983-11-29
DD210217A5 (de) 1984-06-06
DK163105C (da) 1992-06-15
EP0092453B1 (en) 1987-09-02
PT76476B (en) 1985-12-10
FI834364A0 (fi) 1983-11-29
EP0092453A3 (en) 1983-12-07
PT76476A (en) 1983-04-01
GR78163B (enExample) 1984-09-26
IE54706B1 (en) 1990-01-17
IL68250A (en) 1990-02-09
EP0092453A2 (en) 1983-10-26
FI83161C (fi) 1991-06-10
IE830690L (en) 1983-09-29
AU564876B2 (en) 1987-08-27

Similar Documents

Publication Publication Date Title
EP0092453A3 (en) Stable plurilamellar vesicles
GB2128984B (en) Diaza-bicyclic compounds
GB2120248B (en) Polypiperidine compounds
GB8301981D0 (en) Compounds
GB8325337D0 (en) Porphylactic substance
PT77860A (en) Compounds
GB8301042D0 (en) Switch-fuse unit
GB8300723D0 (en) Preparation unit
DE3362221D1 (en) Azolylstyryl compounds
PH20022A (en) 7-substituted-3-vinyl-3-cephem compounds
GB8302397D0 (en) Perfluorobicyclo compounds
DE3363786D1 (en) Dioxocyclobutene compounds
GB2128200B (en) Chloro-triazinyl mondazo compounds
ZA839478B (en) Aralkyltriazole compounds
GB2123725B (en) Coiler-furnace unit
IL68601A0 (en) Eye-protecting means
SG22588G (en) Ergotalkaloids
GB2117178B (en) Switch-fuse unit
ZA832197B (en) Stable plurilamellar vesicles
GB8318467D0 (en) Compounds
ZA828383B (en) Antiglaucoma compounds
GB8318978D0 (en) Aminoimidazolyl compounds
GB8330789D0 (en) Phthalidylammonium compounds
ZA837543B (en) Supports
CS863782A1 (en) Sposob pripravy nizkomolekulovych polymerov styrenu alebo methylmetakrylatu alebo ich vzajomnych kopolymerov